OMIC Singular Genomics Systems Inc
Price (delayed)
$13.01
Market cap
$32.47M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$37.37
Enterprise value
$73.54M
Highlights
OMIC's revenue is up by 28% year-on-year and by 9% since the previous quarter
OMIC's EPS is up by 5% since the previous quarter and by 5% year-on-year
Singular Genomics Systems's debt has increased by 23% YoY but it has decreased by 2.4% QoQ
OMIC's quick ratio is down by 47% year-on-year and by 16% since the previous quarter
Singular Genomics Systems's equity has decreased by 37% YoY and by 12% QoQ
Key stats
What are the main financial stats of OMIC
Market
Valuations
Earnings
Shares outstanding
2.5M
Market cap
$32.47M
Enterprise value
$73.54M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.23
Price to sales (P/S)
11.86
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
27.02
Revenue
$2.72M
EBIT
-$90.75M
EBITDA
-$83.72M
Free cash flow
-$77.98M
Per share
Balance sheet
Liquidity
EPS
-$37.37
Free cash flow per share
-$31.44
Book value per share
$55.76
Revenue per share
$1.1
TBVPS
$88.69
Total assets
$220M
Total liabilities
$82.3M
Debt
$71.79M
Equity
$137.71M
Working capital
$131.75M
Debt to equity
0.52
Current ratio
8.77
Quick ratio
7.92
Net debt/EBITDA
-0.49
Margins
Efficiency
Dividend
EBITDA margin
-3,075.6%
Gross margin
-41.1%
Net margin
-3,375.7%
Operating margin
-3,654.4%
Return on assets
-36.4%
Return on equity
-54.7%
Return on invested capital
-32%
Return on capital employed
-44.7%
Return on sales
-3,333.8%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
OMIC stock price
How has the Singular Genomics Systems stock price performed over time
Intraday
5.09%
1 week
116.47%
1 month
95.93%
1 year
3.5%
YTD
-5.72%
QTD
53.96%
Financial performance
How have Singular Genomics Systems's revenue and profit performed over time
Revenue
$2.72M
Gross profit
-$1.12M
Operating income
-$99.47M
Net income
-$91.89M
Gross margin
-41.1%
Net margin
-3,375.7%
OMIC's revenue is up by 28% year-on-year and by 9% since the previous quarter
Singular Genomics Systems's net margin has increased by 23% YoY and by 13% QoQ
OMIC's operating margin is up by 22% year-on-year and by 13% since the previous quarter
The gross profit has declined by 8% since the previous quarter
Growth
What is Singular Genomics Systems's growth rate over time
Valuation
What is Singular Genomics Systems stock price valuation
P/E
N/A
P/B
0.23
P/S
11.86
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
27.02
OMIC's EPS is up by 5% since the previous quarter and by 5% year-on-year
Singular Genomics Systems's equity has decreased by 37% YoY and by 12% QoQ
The P/B is 10% above the last 4 quarters average of 0.2
OMIC's revenue is up by 28% year-on-year and by 9% since the previous quarter
Efficiency
How efficient is Singular Genomics Systems business performance
The ROE has contracted by 45% YoY and by 7% from the previous quarter
OMIC's ROS is up by 24% year-on-year and by 13% since the previous quarter
The ROA has contracted by 22% YoY
The return on invested capital is up by 9% year-on-year and by 4.2% since the previous quarter
Dividends
What is OMIC's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for OMIC.
Financial health
How did Singular Genomics Systems financials performed over time
Singular Genomics Systems's total assets is 167% higher than its total liabilities
OMIC's quick ratio is down by 47% year-on-year and by 16% since the previous quarter
The company's current ratio fell by 46% YoY and by 15% QoQ
Singular Genomics Systems's debt is 48% lower than its equity
The company's debt to equity has surged by 93% YoY and by 11% QoQ
Singular Genomics Systems's equity has decreased by 37% YoY and by 12% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.